{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alternative medicine", "Breast cancer", "Complementary medicines", "Interaction", "Neoplasm", "Phytotherapy", "Survival"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33748880", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "21"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "21"}], "Language": ["eng"], "ELocationID": ["10.1007/s00432-021-03600-y"], "Journal": {"ISSN": "1432-1335", "JournalIssue": {"Volume": "147", "Issue": "11", "PubDate": {"Year": "2021", "Month": "Nov"}}, "Title": "Journal of cancer research and clinical oncology", "ISOAbbreviation": "J Cancer Res Clin Oncol"}, "ArticleTitle": "Self-medication with herbal medicine and breast cancer survival: a prospective monocentric study.", "Pagination": {"StartPage": "3401", "EndPage": "3407", "MedlinePgn": "3401-3407"}, "Abstract": {"AbstractText": ["The use of complementary and alternative medicine (CAM) is common among breast cancer patients, but less is known about whether CAM influences breast cancer survival. The primary aim of this study was to determine the impact of self-use of herbs on the overall survival.", "This was a prospective study including 110 patients with breast cancer. All patients were questioned about the concept of taking herbs.\u00a0We analyzed the demographic data and the\u00a0overall survival.", "The average age was 51\u00a0years (30-80\u00a0years old). 37 had metastatic disease (33.6%). 48 patients had taken plants (43.6%). 19 patients consumed Graviola (39.6%) and 29 Alenda (60.4%). Overall survival at 3\u00a0years and at 5\u00a0years were, respectively, 96.2% and 82.4% in the absence of plant consumption versus 78.5% and 78.5% in case of plant consumption (p\u2009=\u20090.015).", "This study concluded that self-medication with Graviola or Alenda may be associated with an increase of death risk in patients with breast cancer. Further studies are needed to confirm these results."], "CopyrightInformation": "\u00a9 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature."}, "AuthorList": [{"Identifier": ["0000-0002-4956-9551"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology, Habib Bourguiba Hospital University of Sfax, 3029, Sfax, Tunisia. walabenkridis@yahoo.fr."}], "LastName": "Ben Kridis", "ForeName": "Wala", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology, Habib Bourguiba Hospital University of Sfax, 3029, Sfax, Tunisia."}], "LastName": "Mnif", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology, Habib Bourguiba Hospital University of Sfax, 3029, Sfax, Tunisia."}], "LastName": "Khmiri", "ForeName": "Souhir", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology, Habib Bourguiba Hospital University of Sfax, 3029, Sfax, Tunisia."}], "LastName": "Toumi", "ForeName": "Nabil", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology, Habib Bourguiba Hospital University of Sfax, 3029, Sfax, Tunisia."}], "LastName": "Khanfir", "ForeName": "Afef", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "J Cancer Res Clin Oncol", "NlmUniqueID": "7902060", "ISSNLinking": "0171-5216"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": [], "DescriptorName": "Annona"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["adverse effects", "methods"], "DescriptorName": "Complementary Therapies"}, {"QualifierName": [], "DescriptorName": "Ephedra"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["adverse effects", "methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": [], "DescriptorName": "Self Medication"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cassileth BR, Lucarelli CD (2003) Herb\u2013drug interactions in oncology. BC Decker Inc, Hamilton"}, {"Citation": "Caveny S, Charlet D, Freitqg H, Maier-Stolete M, Starratt A (2001) New observations on the secondarychemistry of world Ephedra (Ephedraceae). Am J Botan 88:1199\u20131208", "ArticleIdList": ["10.2307/3558330"]}, {"Citation": "Chabosseau S, Derbr\u00e9 S (2016) Cancer du sein: recommandations sur l\u2019usage de la phytoth\u00e9rapie. Actual Pharm 55(552):45\u201349"}, {"Citation": "Chen W, Tsai T, Yang C, Kuo T (2010) Effects of ephedra on autonomicnervous modulation in healthy young adults. J Ethnopharmacol 130:563\u2013568", "ArticleIdList": ["10.1016/j.jep.2010.05.056"]}, {"Citation": "Complementary, alternative, or integrative health: what\u2019s in a name? | NCCIH (2016) National center for complementary and integrative health. https://nccih.nih.gov/health/integrative-health . Accessed 30 Nov 2017"}, {"Citation": "Danciu C, Muntean D, Alexa E, Farcas C, Oprean C, Zupko I et al (2018) Phytochemical characterization and evaluation of the antimicrobial, antiproliferative and pro-apoptotic potential of ephedra alata decne. Hydroalcoholic extractagainst the MCF-7 breast cancer cell line. Molecules 1:20\u201324"}, {"Citation": "DiGianni LM, Garber J, Winer EP (2002) Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20:34S-48S", "ArticleIdList": ["12235222"]}, {"Citation": "Drug information\u2014express scripts \u00ae (2018) https://www.expressscripts . com/medco/consumer/ehealth/druginfo/dlmain. jsp?WC=N. Accessed 5 Jan 2018"}, {"Citation": "Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83:777\u2013782", "ArticleIdList": ["10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O"]}, {"Citation": "Firkins R, Eisfeld H, Keinki C, Buentzel J, Hochhaus A, Schmidt T et al (2018) The use of complementary and alternative medicine by patients in routine care and the risk of interactions. J Cancer Res Clin Oncol 144(3):551\u2013557", "ArticleIdList": ["10.1007/s00432-018-2587-7"]}, {"Citation": "Frenkel M, Ben-Arye E, Cohen L (2010) Communication in cancer care: discussing complementary and alternative medicine. Integr Cancer Ther 9:177\u2013185", "ArticleIdList": ["10.1177/1534735410363706"]}, {"Citation": "Huebner J, Muenstedt K, Prott FJ, Stoll C, Micke O, Buentzel J et al (2014a) Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care (Basel Switzerland) 9(1):60\u201363", "ArticleIdList": ["10.1159/000360381"]}, {"Citation": "Huebner J, Micke O, Muecke R, Buentzel J, Prott FJ, Kleeberg U et al (2014b) User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer Res 34(2):943\u2013948", "ArticleIdList": ["24511037"]}, {"Citation": "Integrative medicine: search about herbs | Memorial Sloan Kettering Cancer Center (2018) https://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine/herbs/search . Accessed 5 Jan 2018"}, {"Citation": "John G, Hershman D, Falci L et al (2016) Complementary and alternative medicine use among US cancer survivors. J Cancer Surviv 10:850\u2013864", "ArticleIdList": ["10.1007/s11764-016-0530-y"]}, {"Citation": "Johnson S, Park H, Gross C, Yu J (2018) Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers. JAMA Oncol 10:1375\u20131381", "ArticleIdList": ["10.1001/jamaoncol.2018.2487"]}, {"Citation": "Jun HJ, Park SJ, Kang HJ, Lee GY, Lee N, Park JH et al (2020) The survival benefit of combination therapy with mild temperature hyperthermia and an herbal prescription of Gun-Chil-Jung in 54 cancer patients treated with chemotherapy or radiation therapy: a retrospective study. Integr Cancer Ther 19:1534735420926583", "ArticleIdList": ["10.1177/1534735420926583"]}, {"Citation": "Ma H, Carpenter CL, Sullivan-Halley J, Bernstein L (2011) The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors\u2014results of a prospective study. BMC Cancer 6(11):222", "ArticleIdList": ["10.1186/1471-2407-11-222"]}, {"Citation": "Matthews AK, Sellergren SA, Huo D, List M, Fleming G (2007) Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med 13(5):555\u2013562", "ArticleIdList": ["10.1089/acm.2007.03-9040"]}, {"Citation": "Neuhouser ML, Smith AW, George SM et al (2016) Use of complementary and alternative medicine and breast cancer survival in the health, eating, activity, and lifestyle study. Breast Cancer Res Treat 160:539\u2013546", "ArticleIdList": ["10.1007/s10549-016-4010-x"]}, {"Citation": "Pedersen CG, Christensen S, Jensen AB, Zachariae R (2009) Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer 45(18):3172\u20133181", "ArticleIdList": ["10.1016/j.ejca.2009.09.005"]}, {"Citation": "Peters C, O\u2019neill J, Young J (2005) Is there an association between ephedra and heartfailure? a case series. J Cardiac Fail 11:9\u201311", "ArticleIdList": ["10.1016/j.cardfail.2004.04.003"]}, {"Citation": "Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T (1998) Cancer patients use of nonproven therapy: a 5\u00a0year follow-up study. J Clin Oncol 16:6\u201312", "ArticleIdList": ["10.1200/JCO.1998.16.1.6"]}, {"Citation": "Risberg T, Vickers A, Bremnes RM, Wist EA, Kaasa S, Cassileth BR (2003) Does use of alternative medicine predict survival from cancer? Eur J Cancer 39:372\u2013377", "ArticleIdList": ["10.1016/S0959-8049(02)00701-3"]}, {"Citation": "Werneke U, Ladenheim D, McCarthy T (2004) Complementary alternative medicine for cancer: a review of effectiveness and safety. Cancer Ther 2:475\u2013500"}, {"Citation": "Woo M, Chung S, Kim D (1999) Cis-annonacin and (2,4)-cis-and trans-isoannonacins: cytotoxic monotetrahydrofuran annonaceous acetogenins from the seeds of Annona cherimolia. Arch Pharm Res 5:524\u2013528", "ArticleIdList": ["10.1007/BF02979164"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "29"}, {"Year": "2021", "Month": "3", "Day": "16"}, {"Year": "2021", "Month": "3", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "22", "Hour": "8", "Minute": "34"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33748880", "10.1007/s00432-021-03600-y", "10.1007/s00432-021-03600-y"]}}], "PubmedBookArticle": []}